**Please do like, subscribe and click the bell!!**


Recorded on Wednesday 20th January, this special webinar led by Dr Ross Sadler, Consultant Clinical Scientist, of Oxford University Hospitals NHS Foundation Trust shares an example of how one trust responded to Covid-19 and are taking the next steps to take clinical leadership of patients.

This webinar covers:
• An overview of how Covid-19 reduced the number myeloma screenings and subsequent monoclonal gammopathy detections
• Shared findings and challenges: screenings during the first wave versus workload activity catching-up during Autumn
• Utilising Covid-19 restrictions to make momentous service structure changes to MGUS/Myeloma risk stratification and monitoring

• Exploring the laboratory: taking clinical leadership and actively managing patient monitoring for low-risk MGUS


To see further webinars we are running or for further information, visit our website:
www.sbk-healthcare.co.uk

свернуть